반응식
OC[C:3]1[CH:4]=[C:5]([CH:14]=[CH:15][CH:16]=1)[C:6]([N:8]1[CH2:13][CH2:12][NH:11][CH2:10][CH2:9]1)=[O:7].FC(F)(F)[C:19](=N[Si](C)(C)C)[O:20][Si](C)(C)C.[CH3:32][O:33][C:34]([C:36]1[CH:37]=[CH:38][CH:39]=[C:40]2[C:44]=1[NH:43][CH:42]=[C:41]2[C:45](=[O:49])[C:46](Cl)=[O:47])=[O:35].N1C=CC=CC=1>C(#N)C>[C:6]([N:8]1[CH2:9][CH2:10][N:11]([C:46](=[O:47])[C:45]([C:41]2[C:40]3[C:44](=[C:36]([C:34]([O:33][CH3:32])=[O:35])[CH:37]=[CH:38][CH:39]=3)[NH:43][CH:42]=2)=[O:49])[CH:12]([CH2:19][OH:20])[CH2:13]1)(=[O:7])[C:5]1[CH:4]=[CH:3][CH:16]=[CH:15][CH:14]=1참가 물질
6
반응물 4
생성물 1
시약·촉매·용매 1
실험 절차
To a stirred solution of 3-hydroxylmethyl-benzoylpiperazine XLIX (8.0 mg, 0.036 mmol) in acetonitrile (5 ml) was added BSTFA (8.1 mg, 0.036 mmol). After stirring for 30 minutes at room temperature, (7-methoxycarbonyl-indol-3-yl)-oxoacetyl chloride (8.1 mg, 0.036 mmol) and pyridine (0.5 ml) were added. The reaction was stirred for another 2 hours at room temperature. Concentration under vaccum provided a residue, which was then purified by Shimazu HPLC purification system to give 2 mg of N-(benzoyl)-3-hydroxylmethyl-N′-[(7-methoxycarbonyl-indol-3-yl)-oxoacetyl]-piperazine (Example 98).
후처리
- stirringThe reaction was stirred for another 2 hours at room temperature
- concentrationConcentration under vaccum
- customprovided a residue, which
- customwas then purified by Shimazu HPLC purification system
출처 및 근거
- ORD 기록
- ord-ba2a69e85db842e882cd61fc33b384e6
- 출처 데이터셋
- uspto-grants-2002_10
- 특허 번호
- US06469006B1
연결된 노트
불러오는 중…